Insulin
(asked on 3rd November 2015) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what representations he has made to manufacturers on minimising increases in the price of insulin for treating type 1 diabetes.
This question was answered on 11th November 2015
There have been no such representations or discussions. The prices of branded medicines are controlled by the 2014 Pharmaceutical Price Regulation Scheme or under the statutory scheme established under the Health Service Branded Medicines (Control of Prices and Supply of Information) (No.2) Regulations 2008 and the Health Service Medicines (Information Relating to Sales of Branded Medicines etc.) Regulations 2007.